Christopher Galletta's most recent trade in Trevi Therapeutics Inc was a trade of 4,225 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2025 | 4,225 | 15,775 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 02 Dec 2025 | 4,225 | 26,095 (0%) | 0% | 0.5 | 2,159 | Common Stock |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2025 | 8,550 | 13,110 | - | - | Performance Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,560 | 4,560 | - | - | Performance Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 41,000 | 41,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 13 Dec 2024 | 15,000 | 19,935 (0%) | 0% | 0.5 | 7,665 | Common Stock |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 15,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Galletta Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 28,500 | 28,500 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Christopher Galletta | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) |